Search Results - "Brunner, R C"

Intrathecal baclofen for spastic hypertonia from stroke by Meythaler, J M, Guin-Renfroe, S, Brunner, R C, Hadley, M N

“…We sought to determine whether continuous intrathecal delivery of baclofen can effectively decrease spastic hypertonia due to stroke. Stroke patients with >6…”
Get full text

Hospital waste disposal by incineration. Waste streams, technology, and state requirements by Brunner, C R, Brown, C H

Get more information

Incineration ― today's hot option for waste disposal by BRUNNER, C. R

“…The applicability of incineration to different types of waste, the types of incinerators available, their control, maintenance and economics are examined. For…”
Get full text

Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial by Meythaler, Jay M, Brunner, Robert C, Johnson, Alice, Novack, Thomas A

“…Traumatic brain injury (TBI) caused by a high-speed transportation accident results in a mechanism of injury commonly described as diffuse axonal injury (DAI),…”
Get full text

Cyproheptadine for intrathecal baclofen withdrawal by Meythaler, Jay M, Roper, James F, Brunner, Robert C

“…Meythaler JM, Roper JF, Brunner RC. Cyproheptadine for intrathecal baclofen withdrawal. 2003;84:638-42. To evaluate the efficacy of cyproheptadine in the…”
Get full text

Orally delivered baclofen to control spastic hypertonia in acquired brain injury by Meythaler, Jay M, Clayton, Warren, Davis, Linda K, Guin-Renfroe, Sharon, Brunner, Robert C

“…To determine if oral/systemic delivery of baclofen can effectively decrease spastic hypertonia due to acquired brain injury (traumatic brain injury, stroke,…”
Get full text

A Descriptive Study of Pain and Quality of Life following Guillain-Barré Syndrome: One Year Later by Kogos, Stephen C., Richards, J. Scott, Baños, James, Schmitt, Margaret M., Brunner, Robert C., Meythaler, Jay M., Salisbury, David B., Renfroe, Sharon G., White, Alice J.

“…Guillain-Barré syndrome (GBS) is a debilitating immunopathy that afflicts approximately 5,000 patients annually in the United States, a number that represents…”
Get full text